Status:
UNKNOWN
Avastin for CNV Secondary to Pattern Dystrophy
Lead Sponsor:
University of Trieste
Conditions:
Choroidal Neovascularization Secondary to Pattern Dystrophy
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
PHASE3
Brief Summary
The natural history of subfoveal CNV secondary to Pattern Dystrophy is little understood, but it seems that visual function may be preserved only in the short-term follow-up, with progressive deterior...
Detailed Description
Diagnosis of Pattern Dystrophy Diagnosis of subfoveal CNV Intravitreal injection of avastin (1.25 mg) in operating room under sterile condition. Retreatment on the basis of the detection of disease p...
Eligibility Criteria
Inclusion
- diagnosis of RPD (hyperpigmented yellowish-greyish network, other family members sharing RPD, normal electroretinogram and normal/subnormal electrooculogram)
- classic or occult CNV involving the foveal avascular zone's geometric centre
Exclusion
- conditions other than RPD
- intraocular surgery or capsulotomy within the last 2 or 1 months
- pregnancy
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00391144
Start Date
July 1 2006
End Date
October 1 2006
Last Update
October 23 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste
Trieste, TS, Italy, 34129